What Is a Drug Formulary? How It Affects Injury Patients

James Wong — Founder & Pharmacist, LienScripts | March 7, 2024 | 6 min read

A drug formulary is the list of medications a health insurance plan agrees to cover. For personal injury patients, formulary restrictions are often irrelevant — because pharmacy lien arrangements bypass insurance entirely. Understanding formularies helps PI attorneys explain why certain medications were dispensed through a lien rather than insurance.

This post is for informational purposes only and does not constitute legal advice.

The List That Controls What Your Insurance Will Pay For

Every health insurance plan — commercial, Medicare Part D, Medicaid managed care — maintains a formulary: a tiered list of covered medications. When a physician prescribes a medication that appears on the formulary, the plan pays its share. When a physician prescribes a medication that is not on the formulary — or is on a restrictive tier with high cost-sharing — the patient either pays out of pocket, goes through a lengthy prior authorization process, or goes without.

For the general population, formularies are an important cost-management tool. For personal injury patients, they are frequently a barrier that pharmacy lien arrangements are specifically designed to eliminate.

[!KEY] A drug formulary is an insurer's approved medication list — but in a pharmacy lien arrangement, the formulary is irrelevant because no insurance is billed and the physician's prescription governs what the patient receives.

How Formularies Are Structured

Most commercial health plan formularies use a tiered structure. A typical 4-tier formulary looks like this:

Tier 1 — Preferred generics: Lowest cost-sharing (small copay, often $0–$10). Most common generic medications.

Tier 2 — Non-preferred generics / preferred brands: Moderate cost-sharing. Some brand-name medications with preferred status.

Tier 3 — Non-preferred brands: Higher cost-sharing. Brand medications that are not preferred, often because a generic or cheaper alternative is available.

Tier 4 — Specialty medications: Highest cost-sharing, often 20–30% coinsurance. High-cost specialty drugs including biologics, CGRP inhibitors, certain neuropathic agents, and compound preparations.

Some plans add a Tier 5 for the most expensive specialty medications with coinsurance rather than flat copays — meaning the patient's share can reach hundreds or thousands of dollars per month.

Formulary Restrictions That Affect PI Patients

Personal injury patients often need medications that face significant formulary restrictions:

Step therapy (step edits). The plan requires trying a cheaper medication first before covering the preferred option. For example, a plan may require trying sumatriptan before covering a CGRP inhibitor for post-traumatic migraine. If the patient's clinical history shows sumatriptan is ineffective or contraindicated, the step therapy requirement becomes a barrier to appropriate care.

Prior authorization. Many non-formulary and specialty medications require the prescribing physician to obtain prior authorization — a pre-approval from the insurer — before the plan will pay. See our dedicated post on what prior authorization means for injury patients.

Quantity limits. Formularies often impose quantity limits (e.g., a maximum number of opioid tablets per fill, or limited refills of certain controlled substances). These limits may conflict with a physician's prescribed treatment plan for a serious injury.

Non-covered medications. Certain medications — including many compound preparations, some off-label medications, and certain brand-name drugs — may simply not appear on the formulary at all.

Why Pharmacy Lien Arrangements Bypass Formulary Problems

The fundamental structure of a pharmacy lien arrangement is that the pharmacy dispenses medications without billing insurance — the pharmacy extends credit to the patient, secured by a lien on the patient's eventual PI settlement. This means:

• The formulary is irrelevant to what medications are dispensed.
• No prior authorization is required from the patient's health insurer.
• Step therapy requirements do not apply.
• Quantity limits imposed by the insurer's formulary do not restrict the fill.

The prescribing physician's clinical judgment — not the insurance company's formulary — governs what medications the patient receives. This is particularly valuable in PI cases where the treating physician has prescribed specific medications based on the injury's clinical requirements.

[!KEY] The appropriate standard for evaluating a pharmacy lien item is medical necessity — documented by the MERIT report and the treating physician's records — not whether the medication appeared on any particular insurer's formulary, which is a cost-management tool for a different context entirely.

For PI attorneys and defense adjusters reviewing a pharmacy lien, the lien may include medications that would have been difficult to obtain through insurance (specialty medications, compounds, non-formulary brand agents). The MERIT report from LienScripts explains the clinical rationale for each medication — which is the appropriate standard for evaluating whether it was necessary, not whether it appeared on a formulary.

[!NOTE] If a defense adjuster argues a pharmacy lien should be reduced because a cheaper formulary drug exists, the appropriate response is the MERIT report — the clinical standard for lien review is medical necessity, not insurance coverage.

Formularies and Lien Reduction Discussions

When a defense adjuster or a lienholder is evaluating whether to reduce a pharmacy lien, they sometimes argue that "insurance would have covered a cheaper generic." This argument misunderstands the lien structure for two reasons:

1. The patient may not have had applicable insurance, or the insurer may have denied coverage for this condition.
2. The treating physician prescribed the specific medication for a clinical reason. The formulary equivalent (if one exists) may not have the same efficacy for this patient.

The made-whole doctrine and lien reduction principles govern pharmacy lien negotiations — not the health plan's coverage determinations.

[!KEY] When a defense adjuster argues that a pharmacy lien should be reduced because a generic formulary equivalent exists, the response is that the treating physician's clinical decision to prescribe a specific medication is documented in the medical record and is the governing standard — the MERIT report explains that decision, and formulary economics is not a valid basis for challenging it.

Key Takeaway

A drug formulary is an insurer's preferred medication list used to manage prescription drug costs. For personal injury patients receiving treatment through a pharmacy lien arrangement, formulary restrictions do not apply — the pharmacy lien model is specifically designed to provide access to physician-ordered medications without insurance gatekeeping. When reviewing a pharmacy lien balance, the relevant standard is clinical necessity (documented in the MERIT report), not whether each medication appeared on a particular plan's formulary.